Monika Szymczak-Cendlak

Dr. Monika Szymczak-Cendlak

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KNKarolina Nowicka-Bauer
Karolina Nowicka-Bauer
Monika Szymczak-CendlakMonika Szymczak-Cendlak
Monika Szymczak-Cendlak
Sperm motility is linked to the activation of signaling pathways that trigger movement. These pathways are mainly dependent on Ca2+, which acts as a secondary messenger. The maintenance of adequate Ca2+ concentrations is possible thanks to proper concentrations of other ions, such as K+ and Na+, among others, that modulate plasma membrane potential and the intracellular pH. Like in every cell, ion homeostasis in spermatozoa is ensured by a vast spectrum of ion channels supported by the work of ion pumps and transporters. To achieve success in fertilization, sperm ion channels have to be sensitive to various external and internal factors. This sensitivity is provided by specific channel structures. In addition, novel sperm-specific channels or isoforms have been found with compositions that increase the chance of fertilization. Notably, the most significant sperm ion channel is the cation channel of sperm (CatSper), which is a sperm-specific Ca2+ channel required for the hyperactivation of sperm motility. The role of other ion channels in the spermatozoa, such as voltage-gated Ca2+ channels (VGCCs), Ca2+-activated Cl-channels (CaCCs), SLO K+ channels or voltage-gated H+ channels (VGHCs), is to ensure the activation and modulation of CatSper. As the activation of sperm motility differs among metazoa, different ion channels may participate; however, knowledge regarding these channels is still scarce. In the present review, the roles and structures of the most important known ion channels are described in regard to regulation of sperm motility in animals.

1 December 2018 in Toxins
Verified
Journal Article
Open access
PDF file
MSMarta Spochacz-Santoro
Marta Spochacz-Santoro
Szymon ChowańskiSzymon Chowański
Szymon Chowański
Monika Szymczak-CendlakMonika Szymczak-Cendlak
Monika Szymczak-Cendlak
Filomena LelarioFilomena Lelario
Filomena Lelario
Sabino Aurelio BufoSabino Aurelio Bufo
Sabino Aurelio Bufo
Zbigniew AdamskiZbigniew Adamski
Zbigniew Adamski
Background: Solanaceae plants produce glycoalkaloids (GAs) that affect various physiological processes of herbivorous insects and they are being tested as potential alternatives for synthetic pesticides. They cause lethal and sublethal effects. Nevertheless, their mode of action remains unclear. Therefore, we examined the effects of Solanum nigrum fruit extracts and pure glycoalkaloids on a model beetle, Tenebrio molitor. Methods: Plant extracts or pure alkaloids were added to the food of the larvae for three days. The lipid, glycogen, and protein content in the fat body and the midgut were determined, and the contractility of the heart, hindgut, and oviduct muscles was tested using the video-microscopy technique. Finally, the ultrastructure of the fat body and the midgut was observed using electron microscopy. Results: No lethal effects were noted. Sublethal changes were observed in the content of biomolecules, malformations of organelles, chromatin condensation, and heart and oviduct contractility. The observed effects differed between the tested glycoalkaloids and the extract. Conclusions: Both the extract and pure GAs have a wide range of effects that may result in impaired development, food intake, and reproduction. Some early effects may be used as bioindicators of stress. The effects of the extract and pure alkaloids suggest that the substances produced by the plant may act additively or synergistically.

1 October 2018 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
Szymon ChowańskiSzymon Chowański
Szymon Chowański
ECewa chudzińska
ewa chudzińska
Filomena LelarioFilomena Lelario
Filomena Lelario
EVEmanuela Ventrella
Emanuela Ventrella
PMPawel Marciniak
Pawel Marciniak
Zbigniew AdamskiZbigniew Adamski
Zbigniew Adamski

1 September 2021 in Toxins
Verified
Journal Article
Open access
PDF file
MSMarta Spochacz-Santoro
Marta Spochacz-Santoro
Szymon ChowańskiSzymon Chowański
Szymon Chowański
Monika Szymczak-CendlakMonika Szymczak-Cendlak
Monika Szymczak-Cendlak
PMPawel Marciniak
Pawel Marciniak
Filomena LelarioFilomena Lelario
Filomena Lelario
Patrizia FalabellaPatrizia Falabella
Patrizia Falabella
Glycoalkaloids, secondary metabolites abundant in plants belonging to the Solanaceae family, may affect the physiology of insect pests. This paper presents original results dealing with the influence of a crude extract obtained from Solanum nigrum unripe berries and its main constituent, solasonine, on the physiology of Galleria mellonella (Lepidoptera) that can be used as an alternative bioinsecticide. G. mellonella IV instar larvae were treated with S. nigrum extract and solasonine at different concentrations. The effects of extract and solasonine were evaluated analyzing changes in carbohydrate and amino acid composition in hemolymph by RP-HPLC and in the ultrastructure of the fat body cells by TEM. Both extract and solasonine changed the level of hemolymph metabolites and the ultrastructure of the fat body and the midgut cells. In particular, the extract increased the erythritol level in the hemolymph compared to control, enlarged the intracellular space in fat body cells, and decreased cytoplasm and lipid droplets electron density. The solasonine, tested with three concentrations, caused the decrease of cytoplasm electron density in both fat body and midgut cells. Obtained results highlighted the disturbance of the midgut and the fat body due to glycoalkaloids and the potential role of hemolymph ingredients in its detoxification. These findings suggest a possible application of glycoalkaloids as a natural insecticide in the pest control of G. mellonella larvae.

20 August 2021 in Journal of Comparative Physiology B
Verified
Journal Article
Open access
PDF file
Monika Szymczak-CendlakMonika Szymczak-Cendlak
Monika Szymczak-Cendlak
MGMarek Golebiowski
Marek Golebiowski
Szymon ChowańskiSzymon Chowański
Szymon Chowański
JPJoanna Pacholska-Bogalska
Joanna Pacholska-Bogalska
PMPawel Marciniak
Pawel Marciniak
Małgorzata SłocińskaMałgorzata Słocińska
Małgorzata Słocińska
Insect sulfakinins are pleiotropic neuropeptides with the homology to vertebrate gastrin/cholecystokinin peptide family. They have been identified in many insect species and affect different metabolic processes. They have a strong influence on feeding and digestion as well as on carbohydrate and lipid processing. Our study reveals that sulfakinins influence fatty acids composition in Zophobas atratus oenocytes and regulate insulin-like peptides (ILPs) level in these cells. Oenocytes are cells responsible for maintenance of the body homeostasis and have an important role in the regulation of intermediary metabolism, especially of lipids. To analyze the lipid composition in oenocytes after sulfakinins injections we used gas chromatography combined with mass spectrometry and for ILPs level determination an immunoenzymatic test was used. Because sulfakinin peptides and their receptors are the main components of sulfakinin signaling, we also analyzed the presence of sulfakinin receptor transcript (SKR2) in insect tissues. We have identified for the first time the sulfakinin receptor transcript (SKR2) in insect oenocytes and found its distribution more widespread in the peripheral tissues (gut, fat body and haemolymph) as well as in the nervous and neuro-endocrine systems (brain, ventral nerve cord, corpora cardiaca/corpora allata CC/CA) of Z. atratus larvae. The presence of sulfakinin receptor transcript (SKR2) in oenocytes suggests that observed effects on oenocytes lipid and ILPs content may result from direction action of these peptides on oenocytes.

10 July 2022 in Pharmaceutical Biology
Verified
Journal Article
Open access
Szymon ChowańskiSzymon Chowański
Szymon Chowański
MWMagdalena Joanna Winkiel
Magdalena Joanna Winkiel
Monika Szymczak-CendlakMonika Szymczak-Cendlak
Monika Szymczak-Cendlak
PMPawel Marciniak
Pawel Marciniak
DMDominika Mańczak
Dominika Mańczak
Zbigniew AdamskiZbigniew Adamski
Zbigniew Adamski
Solanaceae glycoalkaloids (SGAs) possess cardiomodulatory activity. This study investigated the potential interaction between verapamil and glycoalkaloids. The cardioactivity of verapamil and glycoalkaloids (α-solanine and α-chaconine) was tested in adult beetle (Tenebrio molitor) myocardium in vitro using microdensitometric methods. The myocardium was treated with pure substances and mixtures of verapamil and glycoalkaloids for 9 min with saline as a control. Two experimental variants were used: simultaneous application of verapamil and glycoalkaloids or preincubation of the myocardium with one of the compounds followed by perfusion with a verapamil solution. We used 9 × 10−6–5 × 10−5 M and 10−9–10−5 M concentration for verapamil and glycoalkaloids, respectively. Verapamil, α-solanine and α-chaconine showed cardioinhibitory activity with IC50 values equal to 1.69 × 10−5, 1.88 × 10−7 and 7.48 × 10−7 M, respectively. When the glycoalkaloids were applied simultaneously with verapamil, an antagonistic effect was observed with a decrease in the maximal inhibitory effect and prolongation of t50 and the recovery time characteristic of verapamil. We also confirmed the expression of two transcript forms of the gene that encodes the α1 subunit of L-type calcium channels in the myocardium and brain with equal transcription levels of both forms in the myocardium and significant domination of the shorter form in the brain of the insect species tested. The results show that attention to the composition of the daily diet during therapy with various drugs is particularly important. In subsequent studies, the nature of interaction between verapamil and SGAs on the molecular level should be checked, and whether this interaction decreases the efficiency of cardiovascular therapy with verapamil in humans.